News

The CHMP recommendation is for the use of Lymphoseek in imaging and intraoperative detection of sentinel lymph nodes draining a primary tumor in adult patients with breast cancer,

The approval is for nintedanib (Vargatef) in combination with docetaxel to treat adults with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor

In addition to the upfront cash payment, each Ambit Biosciences stockholder will receive one Contingent Value Right (CVR), entitling the holder to receive an additional cash payment of

The IND application includes a pivotal Phase III protocol for Neutrolin in hemodialysis patients with a central venous catheter. The multi-centre, randomised, controlled trial is conducted in the

Prior to becoming a public company, Livzon was a principal investor in the $36m private financing round EPIRUS that closed in April 2014. EPIRUS’ Remicade biosimilar BOW015 (infliximab)

The joint laboratory will focus on the discovery and development of new biologic cancer treatments over an initial five-year period. Under the deal, scientists from both organisations will

The oversubscribed round was led by New Enterprise Associates (NEA), and additional new investors participating included OrbiMed Advisors LLC, Wellington Management Company, LLP, Fidelity Biosciences, Foresite Capital Management,

An international group of public and private organisations is collaborating to accelerate development of an innovative heat-stable and low-cost inhaled form of oxytocin to manage postpartum hemorrhage in

Crohn’s disease is a type of inflammatory bowel disease (IBD) which involves the end of the small intestine and the large intestine. The FDA approval represents the eighth